Stock OPRX OPTIMIZERX CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases OptimizeRx Corporation

Equities

OPRX

US68401U2042

Market Closed - Nasdaq
Other stock markets
 21:00:00 10/05/2024 BST 		5-day change 1st Jan Change
10.81 USD -0.92% Intraday chart for OptimizeRx Corporation +1.79% -24.46%
04-29 OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024 CI
04-16 Earnings Flash (OPRX) OPTIMIZERX CORPORATION Posts Q4 Revenue $28.4M MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
OptimizeRx to Participate in Upcoming Investor Conferences 
AQ
OptimizeRx Provides Business Update and Sets First Quarter 2024 Conference Call for May 14, 2024 at 4:30 p.m. ET
AQ
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
AQ
OptimizeRx Reports Strong Fourth Quarter and Full Year 2023 Financial Results
AQ
OptimizeRx : ESG Report
PU
OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
AQ
OptimizeRx : Corporate Presentation
PU
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
AQ
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
AQ
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
AQ
OptimizeRx to Participate in Upcoming Investor Conferences
AQ
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
AQ
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
AQ
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
AQ
OptimizeRx Reports Third Quarter 2023 Financial Results
AQ
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
AQ
OptimizeRx : Third quarter 2023 headline numbers to come in ahead of consensus with revenue for OptimizeRx standalone expected to be between $15.2-$15.5 million and non-GAAP net income expected to be $0.6-$1 million - Form 8-K
PU
OptimizeRx Announces Agreement to Acquire Medicx Health for $95 million to Expand its Omnichannel Reach to Consumers
AQ
OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
AQ
OptimizeRx Expands AI Powered Omnichannel Platform
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPRX Stock
  4. News OptimizeRx Corporation
  5. Press Releases